CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 19 05:51 ET
CSPC PHARMA: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER SALES AGREEMENT
Apr 19 04:53 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 18 05:45 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 17 06:22 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 16 05:59 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 15 05:28 ET
CSPC PHARMA: EXERCISE OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME
Apr 15 05:21 ET
CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024
Apr 2 05:38 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE INJECTION FOR OVERWEIGHT/OBESITY INDICATION OBTAINS CLINICAL TRIAL APPROVAL
Mar 25 05:07 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS OBTAINS DRUG REGISTRATION APPROVAL
Mar 22 04:31 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL
Mar 20 05:25 ET
CSPC PHARMA: CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER
Mar 20 05:22 ET
CSPC PHARMA: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 20 00:06 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039)OBTAINS CLINICAL TRIAL APPROVAL
Mar 18 06:08 ET
CSPC PHARMA: INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 14 07:42 ET
CSPC PHARMA: DATE OF BOARD MEETING
Mar 8 04:39 ET
CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024
Mar 1 03:47 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - INDICATION FOR ACUTE ISCHEMIC STROKE OF MINGFULE (RECOMBINANT HUMAN TNK TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR INJECTION) OBTAINS MARKETING APPROVAL
Feb 4 23:15 ET
CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
Feb 1 04:38 ET
CSPC PHARMA: KEY FINANCIAL INFORMATION OF A SUBSIDIARY FOR THE YEAR ENDED 31 DECEMBER 2023
Jan 24 06:28 ET
No Data
No Data